The RADIANCE CED Study
Recruiting now
Conditions studied: Hypertension, Cardiovascular Diseases, Vascular Diseases
In brief
The RADIANCE CED study is a prospective observational study designed to evaluate the long-term effectiveness of ultrasound renal denervation in lowering blood pressure among patients with uncontrolled hypertension. Data will be collected from electronic health records (EHRs) of Medicare-eligible patients to support generalizability of outcomes to the broader Medicare population. Individual hospital enrollment is not required for this study and IRB exemption has been received by sponsor.
Key facts
- Study ID
- NCT07231757
- Run by
- ReCor Medical, Inc.
- People needed
- 1000
- Starts
- 2025-11-21
- Expected to finish
- 2031-12-31
- Last updated by the study team
- 2026-07-16
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Henry Ford Hospital — Detroit, Michigan, United States (enrolling)
- Henry Ford St. John Hospital — Detroit, Michigan, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.